Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Syndrome of Inappropriate Antidiuresis”

43 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 43 results

Not applicableEnded earlyNCT02545114
What this trial is testing

Tolvaptan for Patients With Acute Neurological Injuries

Who this might be right for
HyponatremiaSIADH
Polderman, Kees, H., MD, PhD 25
Not applicableLooking for participantsNCT07528365
What this trial is testing

Urea for Treatment of Hyponatremia in Patients With SIAD Unresponsive to Fluid Restriction

Who this might be right for
SIAD - Syndrome of Inappropriate Antidiuresis
University of Turin, Italy 20
Not applicableStudy completedNCT03924674
What this trial is testing

SOFI: A Quality Improvement Project to Standardize Use of Intravenous Fluids in Hospitalized Pediatric Patients

Who this might be right for
Intravenous FluidsFluid and Electrolyte ImbalanceADH Inappropriate
Seattle Children's Hospital 106
Not applicableStudy completedNCT01056848
What this trial is testing

International, Multicenter Study of a Twenty-eight Week, Open-label, Titrated Oral Lixivaptan Administration in Patients With Chronic Hyponatremia: Extension to Studies CK-LX3401, 3405, and 3430

Who this might be right for
Hyponatremia With Normal Extracellular Fluid VolumeHyponatremia With Excess Extracellular Fluid Volume
CardioKine Inc. 135
Large-scale testing (Phase 3)Ended earlyNCT01227512
What this trial is testing

Effects of Tolvaptan vs Fluid Restriction in Hospitalized Subjects With Dilutional Hyponatremia

Who this might be right for
HyponatremiaDilutional HyponatremiaInappropriate ADH Syndrome
Otsuka Pharmaceutical Development & Commercialization, Inc. 124
Post-approval studies (Phase 4)WithdrawnNCT00298753
What this trial is testing

Urinary Aquaporine 2 in Patients With Syndrome of Inappropriate ADH-secretion Caused by Treatment With Antiepileptic Medicine

Who this might be right for
Syndrome of Inappropriate ADH-secretion
Regional Hospital Holstebro
Not applicableStudy completedNCT01313975
What this trial is testing

Electrolyte and Fluid Disturbances in Subarachnoid Hemorrhage and Traumatic Brain Injury

Who this might be right for
Electrolyte DisturbancesSubarachnoid HemorrhageTraumatic Brain Injury+1 more
Insel Gruppe AG, University Hospital Bern 85
Not applicableActive Not RecruitingNCT04790175
What this trial is testing

Samsca Post-marketing General Drug Use-results Survey in Patients With Hyponatremia in SIADH

Who this might be right for
Antidiuretic Hormone, Inappropriate Secretion
Otsuka Pharmaceutical Co., Ltd. 300
Large-scale testing (Phase 3)Study completedNCT00264927
What this trial is testing

Efficacy and Safety of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion

Who this might be right for
Inappropriate ADH SyndromeHyponatremia
Sanofi 77
Not applicableUnknownNCT01509170
What this trial is testing

The Clinical and Laboratory Characteristics of Recurrent Drug- Related Hyponatremia

Who this might be right for
HyponatremiaSIADH
Hadassah Medical Organization 500
Not applicableActive Not RecruitingNCT04552873
What this trial is testing

Urea Therapy for Hyponatremia in Subarachnoid Hemorrhage

Who this might be right for
HyponatremiaSubarachnoid HemorrhageSIADH
University Hospital, Grenoble 52
Not applicableStudy completedNCT04987385
What this trial is testing

Effect of Protein Supplementation on Plasma Sodium Levels and Urinary Urea Excretion in Patients With SIAD

Who this might be right for
Syndrome of Inappropriate Antidiuresis (SIAD)
University Hospital, Basel, Switzerland 18
Not applicableUnknownNCT01228682
What this trial is testing

Post-Authorisation Safety Study of Samsca (Tolvaptan) Used in Routine Medical Practice

Who this might be right for
SIADHNon-SIADH HyponatremiaNon-Hyponatremia
Otsuka Frankfurt Research Institute GmbH 200
Not applicableStudy completedNCT02548845
What this trial is testing

An Observational Study to Describe the Adherence to the SEOM Algorithm for the Treatment of Hyponatraemia in Spain

Who this might be right for
HyponatremiaSyndrome of Inappropriate ADH (SIADH) Secretion
Otsuka Pharmaceutical Europe Ltd 70
Not applicableStudy completedNCT04256499
What this trial is testing

Water Load Test Value for Hyponatremia

Who this might be right for
SIAD - Syndrome of Inappropriate AntidiuresisHyponatremia
European Georges Pompidou Hospital 150
Large-scale testing (Phase 3)Study completedNCT00876798
What this trial is testing

A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Tolerability of Oral Lixivaptan Capsules in Subjects With Euvolemic Hyponatremia

Who this might be right for
Euvolemic Hyponatremia
CardioKine Inc. 206
Not applicableStudy completedNCT04744987
What this trial is testing

Changes in Serum Creatinine Levels Can Help Distinguish Hypovolemic From Euvolemic Hyponatremia

Who this might be right for
HyponatremiaHypovolemiaSIADH
Hospital San Carlos, Madrid 122
Large-scale testing (Phase 3)Study completedNCT02729766
What this trial is testing

Effects of Empagliflozin an SGLT2-Inhibitor on Healthy Volunteers With Induced Hypotonic Hyponatremia - the DIVE Study

Who this might be right for
Inappropriate ADH Syndrome
University Hospital, Basel, Switzerland 15
Post-approval studies (Phase 4)Study completedNCT04447911
What this trial is testing

Effects of the SGLT2 Inhibitor Empagliflozin in Patients With Euvolemic and Hypervolemic Hyponatremia

Who this might be right for
HyponatremiaSIADHLiver Failure+1 more
University Hospital, Basel, Switzerland 113
Large-scale testing (Phase 3)Ended earlyNCT00728091
What this trial is testing

A Phase III Study Evaluating the Efficacy and Safety of Satavaptan Versus Placebo in Patients With Dilutional Hyponatremia

Who this might be right for
HyponatremiaInappropriate ADH Syndrome
Sanofi 2
Next Page